History of the discovery, development, and FDA-approval of buprenorphine medications for the treatment of opioid use disorder-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

History of the discovery, development, and FDA-approval of buprenorphine medications for the treatment of opioid use disorder

Published:2023-03 Issue: Volume:6 Page:100133
ISSN:2772-7246
Container-title:Drug and Alcohol Dependence Reports
language:en
Short-container-title:Drug and Alcohol Dependence Reports

Author:

Heidbreder Christian^ORCID,Fudala Paul J.,Greenwald Mark K.

Publisher

Elsevier BV

Reference126 articles.

1. Pharmacokinetic evaluation of once-weekly and once-monthly buprenorphine subcutaneous injection depots (CAM2038) versus intravenous and sublingual buprenorphine in healthy volunteers under naltrexone blockade: an open-label phase 1 study;Albayaty;Adv. Ther.,2017

2. Diagnostic and Statistical Manual of Mental Disorders,2013

3. Disparities in access to opioid treatment programs and office-based buprenorphine treatment across the rural-urban and area deprivation continua: a US nationwide small area analysis;Amiri;Value Health,2021

4. Treating opioid use disorder with a monthly subcutaneous buprenorphine depot injection: 12-month safety, tolerability, and efficacy analysis;Andorn;J. Clin. Psychopharmacol.,2020

5. Addressing racial and ethnic disparities in the use of medications for opioid use disorder;Andraka-Christou;Health Aff. (Millwood),2021

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nor-LAAM loaded PLGA microparticles for treating opioid use disorder;Journal of Controlled Release;2024-09

2. Mobile clinics for opioid use disorders: What they do and how they do it. A qualitative analysis;Journal of Substance Use and Addiction Treatment;2024-09

3. Evolution of the substance use landscape: Implications for contingency management;Journal of Applied Behavior Analysis;2024-08-28

4. Federal Impacts on Buprenorphine Prescribing in Washington State, 2012 to 2022;American Journal of Public Health;2024-07

5. Community buprenorphine continuation post-release following extended release vs. sublingual buprenorphine during incarceration: a pilot project in Maine;Health & Justice;2024-06-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3